Work

Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors

Year: 2017

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.117.244392

Authors: Michael Z. Leonard, Shakiru O. Alapafuja, Lipin Ji, Vidyanand G. Shukla, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Jack Bergman, Brian D. Kangas

Institutions: Northeastern University, Harvard University, McLean Hospital, MAKScientific (United States)

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute on Drug Abuse

Awards: Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention, Drug Self Administration and Withdrawal Effects on Cognitive Function

OpenAlex ID: W2757614918

FWCI: 0.955

Cites: 50

Cited by: 10

Related to: 10